Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Colchicine for progression of moderate aortic stenosis
NL-OMON51747Phase 3Recruiting
- Sponsor
- Radboud University Medical Center
- Start
- Dec 2022
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in aortic stenosis (AS) comparing Colchicine with Placebo (2 arms). Primary endpoint: Change in aortic valve calcium score. Started Dec 2022; status: recruiting.
02
Drugs
colchicine
03
Conditions
aortic stenosis (AS)
Beyond the preview
Go deeper on NL-OMON51747.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON51747.